New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention

SAN DIEGO, March 16, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced a strategic collaboration with Veritas Genetics Powered By Fuze Health to form a consortium that aims to bring preventive genomics into everyday healthcare through health insurance plans in the United States and under other global markets, setting a new standard for proactive health management. By combining clinical-grade sequencing, advanced informatics, and member-ready reporting, the collaboration supports an integrated data ecosystem to advance research, drug discovery, and clinical trial optimization.

Built around a shared vision for data-driven precision medicine, the collaboration aims to integrate whole-genome sequencing into proactive healthcare. It will empower individuals to proactively leverage whole-genome data to support earlier identification of disease risk, more personalized prevention strategies, and improved long-term health outcomes.